HIV Research and Clinical Practice

Aims & Scope

HIV Research and Clinical Practice is devoted to presenting information on the latest developments in HIV/AIDS clinical and translational research, as well as advances in care that directly affect clinical practice.

This journal enables readers to obtain the most up-to-date, innovative research from around the world.

In an era of increasingly well tolerated antiretroviral therapy (ART) much focus of research in the HIV field is examining the complex interplay of inflammation, ageing, and the development of chronic comorbidities in persons living with HIV infection (PLWH).

HIV Research and Clinical Practice aims to provide an authoritative forum for this area, with a focus on impactful clinical and translational research, as well as advances in clinical care.

This international, peer-reviewed journal also intends to publish research undertaken with strong implementation science principles, whether supporting testing and treatment for HIV, best practices in prevention, or acute or chronic aspects of HIV care.

The overarching principle is to improve quality of care, and quality of life, for all PLWH.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Medline

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• HIV and COVID-19: review of clinical course and outcomes

  Citation: 54

  Authors: Lauren K., Kevin F., Sarah E., Amelia J., Soraya, Jesse J., Steven C., Kristine M.

• Patient-reported tolerability and acceptability of cabotegravir + rilpivirine long-acting injections for the treatment of HIV-1 infection: 96-week results from the randomized LATTE-2 study

  Citation: 28

  Authors: Miranda, Federico, Anthony, Moti, Roger, Hans, Viviam, David, Sandy, Joseph, William, David

• COVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: the MACS/WIHS combined cohort study

  Citation: 24

  Authors: Gypsyamber, Gayle, Deborah, Seble, Maria L., Catalina, Anjali, Frank J., Phyllis C., Roger, Mirjam-Colette, Cecile D., Charles R., Audrey L., Joseph B., Ada A.

• Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research

  Citation: 21

  Authors: Karine, John, Lynda, Jeff, Danielle M., Brandon, Mallory O., Parya, John A., Jeremy, Michael J.

• Study protocol for the targeting effective analgesia in clinics for HIV (TEACH) study – a cluster randomized controlled trial and parallel cohort to increase guideline concordant care for long-term opioid therapy among people living with HIV

  Citation: 19

  Authors: Marlene C., Judith I., Jane M., Jonathan, Christin, Debbie M., Alexander Y., Meg, Christopher, Kristen, Catherine, Leah S., Christine, Carly, Melissa C., Kishna, Catherine E., Wendy S., Carlos, Jeffrey H.

• Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting

  Citation: 16

  Authors: Jose L., Marta, María, Pilar, Miguel A, María Jesús, Santiago

• Changes in central adipose tissue after switching to integrase inhibitors

  Citation: 16

  Authors: Paula, Han, Hongyu, Jovana, Guido, Stefano, Giulia, Federica, Marianna, Cristina, Giovanni, Jordan E.

• Quality of life of older women living with HIV: comparative assessment of physical and mental health-related markers using a large Canadian Sexual and Reproductive Health Cohort Study

  Citation: 12

  Authors: Roula, Nisha, Ying, Carmen H., Wangari, Tracey, Kath, Alexandra, Angela, Robert, Mona

• Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients

  Citation: 12

  Authors: Francesca, Simone, Alberto, Arturo, Gianmaria, Roberto, Massimiliano, Simona

• Impact of the COVID-19 pandemic situation on HIV care in Liège, Belgium

  Citation: 11

  Authors: Majdouline, Nicolas, Nathalie, Karine, Dolores, Michel, Gilles